CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Assessment of the efficacy of targeted PDA-66 therapy in a PC-3 Prostate Cancer Xenograft Model using [ 18 F]FDG and [ 18 F]FLT PET/CT and MRI
DOI 10.1055/s-0040-1708319
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSM Schwarzenböck, S Sender, C Bergner, A Velicu, C Schlie, M Joksch, A Pews-Davtyan, R Schwarz, D Zechner, J Stenzel, T Lindner, A Moeller, J Förster, M Guliyev, B Hinz, B Vollmar, C Junghanß, M Beller, BJ Krause, HM Escobar
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
Assessment of the efficacy of targeted PDA-66 therapy in a PC-3 Prostate Cancer Xenograft Model using [ 18 F]FDG and [ 18 F]FLT PET/CT and MRI
Zitieren
Zitierempfehlung
SM Schwarzenböck, S Sender, C Bergner, A Velicu, C Schlie, M Joksch, A Pews-Davtyan, R Schwarz, D Zechner, J Stenzel, T Lindner, A Moeller, J Förster, M Guliyev, B Hinz, B Vollmar, C Junghanß, M Beller, BJ Krause, HM Escobar (2020) Assessment of the efficacy of targeted PDA-66 therapy in a PC-3 Prostate Cancer Xenograft Model using [ 18 F]FDG and [ 18 F]FLT PET/CT and MRI. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708319
Mit CareLit weiterarbeiten